# Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL

> **NCT02314273** · PHASE4 · COMPLETED · sponsor: **Shanghai Children's Medical Center** · enrollment: 120 (actual)

## Conditions studied

- Pancytopenia Due to Chemotherapy

## Interventions

- **DRUG:** rhIL-11

## Key facts

- **NCT ID:** NCT02314273
- **Lead sponsor:** Shanghai Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314273, "Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02314273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*